Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Modavar Pharmaceuticals
FDA Inspection
•Modavar Pharmaceuticals•January 27, 2023

Modavar Pharmaceuticals – FDA Inspection, Jan 27, 2023

Record Details

This FDA Inspection record concerns Modavar Pharmaceuticals, with an inspection on January 27, 2023, issued by the Baltimore District Office.

Company
Modavar Pharmaceuticals
Inspection Date
January 27, 2023
Office
Baltimore District Office
People
  • Amy N. Chen (FDA Associated Person)
  • Jazmine N. Brown
  • Kathleen M. Jordan
View Company Profile

ID · d26160e6-dfa9-4457-8cd6-d8724c6675ac

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1196541
FDA center
Human Drugs
Project area
Generic Drug Evaluation
Outcome
Form 483 issued

FDA Citations

8
  1. 21 CFR 211.111Establishment of time limitations
  2. 21 CFR 211.160(b)(2)In-process sample representation/identification
  3. 21 CFR 211.166(a)(1)Sample size - test intervals
  4. 21 CFR 211.192Investigations of discrepancies, failures
  5. 21 CFR 211.63Equipment Design, Size and Location
  6. 21 CFR 211.68(b)Backup file not maintained
  7. 21 CFR 211.84(d)(2)Component written specification
  8. 21 CFR 211.68(b)Computer control of master formula records

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Modavar Pharmaceuticals

1
DateClassificationOfficeProject area
November 15, 2024Not classifiedBaltimore District Office
Other documents for Modavar Pharmaceuticals
  • FDA Inspection 1260535 - 2024-11-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Modavar Pharmaceuticals
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.